[11C] RO15-4513
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [11C] RO15-4513, covering 2019-09-30 to 2019-09-30. Get the full timeline:
Most recent: Clinical Trial Update: Open Label, Adaptive, Parallel Group PET Study Using RO7017773 And [11C] RO15-4513 [Phase 1]